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We investigated the association between subclinical cardiovascular diseases assessed by
MRI examination and symptoms of dizziness and vertigo in participants of a population-
based sample.
Methods
Data from 400 participants (169 women) aged from 39 to 73 of a cross-sectional MRI sub-
study of the “Kooperative Gesundheitsforschung in der Region Augsburg” (KORA) FF4
study from the south of Germany was used. MRI determined subclinical cardiovascular dis-
eases include left and right ventricular structure and function as well as the presence of
carotid plaque and carotid wall thickness. Cerebrum diseases include white matter lesions
(WML) and cerebral microbleeds (CMB). The main outcomes of dizziness and vertigo were
assessed by standardized interview. Logistic regression models were applied and adjusted
odds ratios (OR) with 95% confidence intervals (CI) were provided.
Results
Lifetime and 12-month prevalence of dizziness and vertigo were 30% (95%CI 26% to 35%)
and 21% (95%CI 17% to 26%) respectively in this sample. On multivariable analysis, car-
diac and carotid measurements were not associated with dizziness and vertigo excluding
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orthostatic vertigo (20%, 95CI 16% to 24%). Only in male participants, there was a signifi-
cant association between WML and the presence of dizziness and vertigo (OR = 2.95, 95%
CI 1.08 to 8.07). There was no significant association of CMB with dizziness and vertigo.
However, CMB and WML were tending to associate with a higher risk of dizziness and
vertigo in the whole sample (CMB: OR = 1.48, 95%CI 0.70; 3.15; WML: OR = 1.71, 95%CI
0.80 to 3.67;), in persons with prediabetes and diabetes (WML: OR = 2.71, 95%CI 0.89 to
8.23) and in men with normal glucose metabolism (CMB: OR = 2.60, 95%CI 0.56 to 12.0;
WML: OR = 3.08, 95%CI 0.58 to 16.5).
Conclusions
In this sample of participants without manifest cardiovascular diseases, subclinical left
and right ventricular function and carotid structure were consistently not associated with
dizziness and vertigo. Subclinical cerebrum measurements, however, tend to increase
the risk for dizziness and vertigo, especially in men and in persons with prediabetes or
diabetes.
Introduction
Dizziness and vertigo are among the most common complaints in the general population lead-
ing to a medical consultation [1]. Symptoms increase with age [2] and are associated with dis-
ability and reduced quality of life [3]. Peripheral vestibular disorders are frequent causes for
dizziness and vertigo with benign paroxysmal positioning vertigo as the most frequent form of
peripheral vestibular disorders with a lifetime prevalence of 2% in the general population [4].
Other, less-frequent peripheral forms of vestibular disorders include Menière’s disease and
vestibular neuritis. Central vestibular forms of vertigo include cerebrovascular diseases, brain
stem and cerebellar lesions, infections, and vestibular migraine [5]. In aged adults, the ageing
of vestibular and proprioceptive systems and, most notably, medication are potential risk fac-
tors for dizziness and vertigo [6].
Besides this, several studies have demonstrated an association of dizziness and vertigo
with abnormal heart rhythm, congestive heart failure, heart valve failure and stroke [5–7].
Although the association seems straightforward, these conditions are rather rare [5] and the
independency of other risk factors is often not clear. In a population-based study, angina
pectoris, myocardial infarction and stroke were associated with vestibular vertigo only
when adjusted for age and sex, but not in further multivariable adjusted analysis, in which
hypertension appeared as an independent cardiovascular risk factor for vestibular vertigo
[1].
In most of the studies investigating causes of dizziness and vertigo, cardiovascular diseases
had been measured by standardized medical interviews asking for self-reported diagnosed
prevalence [1, 7]. Magnetic resonance imaging (MRI) provides an alternative method to mea-
sure a broad range of cardiovascular phenotypes with a higher validity and with continuous
subclinical characteristics. Therefore, the aim of the present analysis was to investigate the
association between subclinical cardiovascular disease assessed by MRI examination and
symptoms of dizziness and vertigo in healthy subjects of a community-based sample.
Cardiovascular disease and dizziness
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Data of the study project “Kooperative Gesundheitsforschung in der Region Augsburg”
(KORA) FF4 from the south of Germany was used for the present analysis. Of all 4261 partici-
pants of the KORA S4 baseline study, 2279 residents of the city of Augsburg and two sur-
rounding counties also participated in the 14-year follow-up FF4 study conducted between
2013 and 2014 [8]. In a FF4 MRI sub-study, a number of 400 FF4 participants (169 women)
aged 39 to 73 years without validated stroke, myocardial infarction, arterial vessel occlusion or
any contraindication for MRI examinations reported previously [9] could be examined by
MRI. Sample size differed between cardiovascular exposure groups of left ventricular function
(N = 381), right ventricular function (N = 365), carotid plaque (N = 264) and cerebrum abnor-
malities (N = 386) due to insufficient image quality and missing imaging data.
The investigations were carried out in accordance with the Declaration of Helsinki, includ-
ing written informed consent of all participants. All study methods were approved by the eth-
ics committee of the Bavarian Chamber of Physicians, Munich (S4: EC No. 99186 and for
genetic epidemiological questions 05004, F4 and FF4: EC No. 06068). The MRI examination
protocol was further approved by the ethics committee of the Ludwig-Maximilian-University
Hospital, Munich.
MRI examination and cardiovascular measurements
All examinations were performed at a 3 Tesla Magnetom Skyra (Siemens AG, Healthcare Sec-
tor, Erlangen Germany) using an 18 channel body coil in combination with the table-mounted
spine matrix coil. Subject position was supine. All subjects underwent an imaging protocol
that comprised following sequences: 4-chamber view steady state free precession (SSFP),
Short-axis stack SSFP (cardiac imaging); axial blackblood T1 weighted fat saturated (T1w fs
ax) (carotid plaque); three dimensional T2 weighted fluid attenuated inversion recovery (T2w
FLAIR 3D), and axial susceptibility weighted imaging (SWI ax) (brain).
Left ventricular function. The cine-SSFP sequences were evaluated semi-automatically
using commercially available software (cvi42, Circle Cardiovascular Imaging, Calgary, Can-
ada). Following automatic contour detection of the left ventricular endocardial and epicardial
border, all borders were corrected manually, if necessary. End-diastolic and end-systolic phase
were identified. Established left ventricular volumetric data were derived according to current
guidelines [10] and included end-diastolic volume and end-systolic volume with calculated
stroke volume (end-diastolic volume minus end-systolic volume) and ejection fraction ((stroke
volume/end-diastolic volume)100) as well as end-systolic and end-diastolic myocardial mass.
Right ventricular function. Right ventricular function parameters were derived by man-
ual segmentation of the right ventricular endocardial border on axial cine-SSFP sequences
using dedicated software (cvi42, Circle Cardiovascular Imaging, Calgary, Canada). Parameters
included end-diastolic volume and end-systolic volume with calculated stroke volume and
ejection fraction.
Assessment of carotid plaque. Presence of plaque, measures of plaque burden and gross
composition of carotid plaque were determined on black-blood T1w fs ax in both carotid
arteries according to the modified American Heart Association (AHA) classification system
[11]. Presence of plaque was defined as eccentric plaque (i.e. wall thickening) with or without
calcification (AHA lesion type III–VII). Boundaries of the vessel lumen and the vessel wall
were analysed using a commercially available semiautomatic dedicated software tool (CAS-
CADE, University of Washington, Seattle, US) [12]. If necessary, manual corrections were
Cardiovascular disease and dizziness
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performed. Based on these, values for wall area and lumen area, as well as maximum wall
thickness were derived. For analysis of plaque burden irrespective of vessel size the normalized
wall-index was calculated by division of wall area by the entire vessel area.
White matter lesions and microbleeds. White matter lesions (WML) were graded on
T2w FLAIR 3D images according to the age-related white matter changes scale (ARWMC)
[13] in five brain areas in the left and right hemisphere, respectively. In each of the areas the
ARWMC score can take values from 0 to 3. Presence of WML was defined as an ARWMC
score>1 in any of the analysed areas. In addition, for sensitivity analysis, WML degree vari-
ables were calculated. First, ARWMC score was categorized as 0: ARWMC score = 0; 1:
ARWMC score = 1; 2: ARWMC score = 2; 3: ARWMC score = 3 (as the maximum score in
any of the ten analysed areas). Second, total ARWMC score summed scores of all areas,
thereby ranging from 0 to 30 and total ARWMC score was further categorized as: 0: total
ARWMC score = 0; 1: total ARWMC score = 1|2; 2: total ARWMC score = 3|4; 3: total
ARWMC score = 5|6; 4: total ARWMC score>6.
Cerebral microbleeds (CMB) were defined as small, foci of signal loss (2 mm) on SWI ax
and counted in the lobar, deep, or infratentorial left or right hemisphere. Symmetric signal
loss in the globus pallidum, most likely calcification, flow void artifact of the pial blood vessels,
and intracerebral lesions with a hemorrhagic component were excluded. Besides investigating
total CMB, participants were also divided into groups of people with microbleeds in lobar
brain regions only, and people with microbleeds in deep or infratentorial regions.
Measurements of dizziness and vertigo
Prevalence of dizziness and vertigo was measured by standardised face-to-face interview using
questions from the balance section of the National Health and Nutrition Examination Survey
Questionnaire for life-time prevalence: “Have you ever had vertigo or dizziness or difficulty
with balance?” and 12 months prevalence: ‘‘During the last 12 months, have you had vertigo or
dizziness or difficulty with balance?”. We used a combination of dizziness and vertigo as out-
come since study participants quite often are not able to distinguish between dizziness and ver-
tigo symptoms and further neuro-otological diagnostic was not available. For main analyses,
12 months prevalence of dizziness and vertigo excluding orthostatic vertigo was used. Individ-
uals were defined as suffering from orthostatic vertigo if vertigo was only triggered by standing
up too fast.
Co-variables
Health related co-variables were assessed by standardized interview, basic health examinations,
laboratory analyses or medication record. Smoking status differentiated between never-
smoker, ex-smoker and current smoker. Body mass index (BMI) was calculated as weight
divided by squared height (kg/m2) and waist circumference was measured in cm to the closest
0.1 cm at the smallest position between the lower rib and the upper margin of the iliac crest.
Body surface area (BSA) was calculated according to the Du Bois formula [14]:
(BSA = 0.007184×(height in cm)0.725×(weight in kg)0.425.
Systolic and diastolic blood pressure (BP) were measured three times at the right arm of
seated participants after a five-minute resting period and three-minute resting periods between
reading. The mean of the second and third BP measurement was used for the present analyses.
An oscillometric digital BP monitor (HEM-705CP, Omron Corporation, Tokyo, Japan) was
used and one of two cuff sizes was applied. Hypertensive participants had an increased systolic
BP (140 mmHg), an increased diastolic BP (90 mmHg) or used antihypertensive medica-
tion under awareness of having hypertension.
Cardiovascular disease and dizziness
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Diabetes was defined as a 2-hour plasma glucose concentration measured by oral glucose
tolerance test (OGTT)200 mg/dl and/or a fasting glucose level125 mg/dl. Prediabetes was
characterized as a 2-hour serum glucose concentration measured by OGTT ranging between
140 and 199 mg/dL and as a fasting glucose level between 110 and 124 mg/dL. Subjects without
diabetes or prediabetes were described as subjects with normal glucose metabolism. Labora-
tory measurements including glucose and HbA1c as well as total cholesterol, high- and low-
density lipoprotein cholesterol were described elsewhere [15].
Statistical analyses
Baseline characteristics of subjects with and without lifetime prevalence of dizziness and ver-
tigo were displayed as absolute numbers and percentages or median and interquartile range
according to categorical or continuous data types. Characteristic differences were evaluated by
χ2-test or by Wilcoxon rank-sum test.
Logistic regression models were used to assess the associations between subclinical cardio-
vascular measurements and lifetime prevalence of dizziness and vertigo and 12-month preva-
lence of dizziness and vertigo excluding orthostatic vertigo. Continuous independent variables
were divided by their standard deviation (SD) to demonstrate a SD increment in risk factors.
Adjusted odds ratios (OR) with 95% confidence intervals (CI) were provided. Associations of
cardiovascular measurements with dizziness and vertigo were adjusted for age, sex, BMI,
hypertension and diabetes mellitus to exclude confounding bias. Left and right ventricular
structure and function were additionally indexed by BSA. Linearity assumption of logistic
regression was verified by testing multivariable regression spline models. In further analyses,
statistical models were additionally adjusted for sampling weights considering differences
between the study sample (n = 400) and the entire KORA cohort (n = 2279, median age = 60
years, 48% men, 15% diabetics) without changed findings. In sensitivity analyses, logistic
regression models were realized separately for women and men as well as for different diabetic
status. A p-value <0.05 was used to determine statistical significance. Data were analyzed by
statistical software of Stata 14.1 (Stata Corporation, College Station, TX, U.S.A.).
Results
Lifetime prevalence of dizziness and vertigo was 30% (95%CI 26% to 35%) in this sample.
Study participants with lifetime dizziness and vertigo were slightly older (median age = 58
years), had a higher proportion of women (50%) and never-smokers (45%) compared to par-
ticipants without lifetime dizziness and vertigo (56 years, p = 0.372; 39% women, p = 0.030;
33% never-smoker, p = 0.005; Table 1). BMI, systolic and diastolic BP as well as HbA1c levels
did not differ between the two groups. More baseline characteristics of the study sample are
presented in Table 1.
Cardiovascular MRI parameters
The cardiac functions stroke volume and ejection fraction of left and right ventricle were simi-
lar between groups with and without lifetime dizziness and vertigo. Right ventricle end-dia-
stolic volume and left ventricle myocardial masses were non-significantly lower in participants
with dizziness and vertigo compared to the other group Table 2. Presence rate of right and left
carotid artery plaque was higher in participants without dizziness and vertigo (25% vs. 14%,
p = 0.036), whereas normalized wall index and mean wall thickness were similar between both
groups. In the analysis for cerebrum characteristics, the presence of WML and CMB were
more prevalent in participants with dizziness and vertigo (14%, 15%, respectively) compared
Cardiovascular disease and dizziness
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to participants without dizziness and vertigo (11%, 12%; Table 2) but without statistical
significance.
Association of cardiovascular MRI parameters with dizziness and vertigo
Multivariable adjusted logistic regression models did not reveal any association between car-
diovascular MRI phenotypes and dizziness and vertigo (Table 3). The highest non-significant
ORs for lifetime dizziness and vertigo and 12-month dizziness and vertigo excluding ortho-
static vertigo were observed for presence of WML (OR = 1.26, 95%CI 0.63 to 2.49; OR = 1.71,
95%CI 0.80 to 3.67; respectively) and CMB (OR = 1.40, 95%CI 0.72 to 2.70; OR = 1.48, 95%CI
0.70 to 3.15). In sensitivity analyses, the relation between WML and 12-month dizziness and
vertigo revealed only significance in men (OR = 2.95, 95%CI 1.08 to 8.07), and showed higher
non-significant effects in persons with prediabetes or diabetes (OR = 2.71, 95%CI 0.89 to 8.23)
(Fig 1) and in men with normal glucose metabolism (OR = 3.08, 95%CI 0.58 to 16.5). Using
WML degree variables, no significant associations between degree of WML and dizziness and
vertigo were detected either in the whole sample (S1 Table) or in subgroups of sex and diabetes
status (data not shown). The relation between CMB and 12-month dizziness and vertigo
revealed to be non-significantly stronger in men (OR = 1.58, 95%CI 0.55 to 4.54) (Fig 2) and
in men with normal glucose metabolism (OR = 2.60, 95%CI 0.56 to 12.0). Differentiating
Table 1. Baseline characteristics of the study sample according to lifetime prevalence of dizziness and vertigo.
With dizziness and vertigo Without dizziness and vertigo p-value
N = 121 N = 279
Age (years) 58 (50–64) 56 (48–64) 0.372
Men 60 (49.6%) 171 (61.3%) 0.030
Smoking status 0.005
Never-smoker 54 (44.6%) 92 (33.0%)
Ex-smoker 54 (44.6%) 120 (43.0%)
Current smoker 13 (10.7%) 67 (24.0%)
BMI (kg/m2) 27.1 (24.5–30.8) 27.5 (24.8–30.9) 0.927
BSA (m2) 1.9 (1.8–2.1) 2.0 (1.8–2.1) 0.045
Waist circumference (cm) 98 (89–107) 100 (90–107) 0.553
Systolic BP (mmHg) 120 (109–131) 121 (108–131) 0.861
Diastolic BP (mmHg) 75 (69–81) 75 (68–81) 0.932
Hypertension 39 (32.2%) 97 (34.8%) 0.623
Diabetic status 0.305
Normal glucose metabolism 79 (65.3%) 164 (58.8%)
Prediabetes 25 (20.7%) 78 (28.0%)
Diabetes 17 (14.1%) 37 (13.3%)
HbA1c (%) 5.4 (5.2–5.6) 5.4 (5.3–5.7) 0.360
Glucose (mg/dl) 98 (91–109) 99 (93–110) 0.630
HDL-C (mg/dl) 62 (49–75) 59 (48–72) 0.172
LDL-C (mg/dl) 139 (120–162) 137 (114–160) 0.620
Total cholesterol (mg/dl) 220 (193–248) 214 (190–239) 0.253
Data are given as number (percentage) or median (25th and 75th percentile).
p-values from χ2 test or Wilcoxon rank-sum test
BMI, body mass index; BSA, body surface area; BP, blood pressure; HbA1c, hemoglobin A1c; HDL-C, high-density-lipoprotein cholesterol; LDL-C, low-
density-lipoprotein cholesterol.
https://doi.org/10.1371/journal.pone.0184858.t001
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between lobar CMB and deep or infratentorial CMB did not change the non-significant results
substantially (S2 Table).
Discussion
This first investigation of the role of several subclinical cardiovascular and cerebrovascular dis-
ease parameters for symptoms of dizziness and vertigo in a population-based sample revealed
no association of MRI determined left and right ventricular function as well as carotid artery
structure, WML and CMB with 12-month prevalence of dizziness and vertigo excluding exclu-
sive orthostatic vertigo. However, the cerebrovascular parameters WML and CMB were
slightly but not significantly increased in participants with dizziness and vertigo and especially
in men and prediabetic and diabetic participants.
Left and right ventricular heart function
The finding of no association of reduced left and right ventricular function with dizziness is in
line with a population-based study of around 3000 participants aged 65 years and older that
observed no association between self-reported cardiovascular disease and dizziness problems
[7]. However, in the study above, self-reported abnormal heart rhythm was associated with
increased risk of dizziness (OR = 1.9, 95%CI 1.2 to 2.8). Another study of around 5000 partici-
pants found an increased risk for vestibular vertigo in participants with self-reported coronary
heart disease (OR = 2.1, 95%CI 1.1 to 3.8) and cardiovascular disease (OR = 2.0, 95%CI 1.1 to
3.6) including angina pectoris and myocardial infarction after adjustment for age and sex but
without statistical significance after multivariable adjustment [1]. In our study, we excluded
participants with overt cardiovascular disease to characterize subclinical cardiovascular disease
Table 2. Cardiovascular MRI characteristics of the study sample according to lifetime prevalence of dizziness and vertigo.
MRI parameter With dizziness and vertigo Without dizziness and vertigo p-value
Left ventricle N = 112 N = 269
End-diastolic volume (ml) 128 (103–152) 124 (108–149) 0.702
End-systolic volume (ml) 38 (29–51) 36 (29–49) 0.710
Stroke volume (ml) 87 (75–103) 87 (74–101) 0.963
Ejection Fraction (%) 71 (64–74) 70 (64–75) 0.756
Myocardial mass, diastolic (g) 134 (115–164) 143 (119–161) 0.287
Myocardial mass, systolic (g) 137 (112–163) 144 (118–167) 0.192
Right ventricle N = 108 N = 257
End-diastolic volume (ml) 159 (129–186) 167 (139–193) 0.115
End-systolic volume (ml) 76 (56–94) 77 (61–95) 0.387
Stroke volume (ml) 85 (70–97) 87 (73–100) 0.311
Ejection Fraction (%) 53 (48–58) 53 (48–58) 0.773
Carotid artery (right and left) N = 89 N = 175
Presence of plaque (AHA lesion type III-VII) (%) 12 (13.5%) 43 (24.6%) 0.036
Normalized wall index 0.43 (0.40–0.45) 0.42 (0.40–0.45) 0.689
Mean wall thickness (mm) 0.73 (0.68–0.80) 0.73 (0.69–0.79) 0.853
Cerebrum N = 117 N = 269
Presence of white matter lesions (%) 16 (13.7%) 30 (11.2%) 0.482
Presence of cerebral microbleeds (%) 18 (15.4%) 31 (11.7%) 0.314
Data are given as number (percentage) or median (25th and 75th percentile).
p-values from χ2 test or Wilcoxon rank-sum test
https://doi.org/10.1371/journal.pone.0184858.t002
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status, and we used more sensitive MRI measurements of continuous heart function
parameters.
Although cardiovascular diseases are observed and discussed as causes of dizziness and ver-
tigo in the literature reviews of studies with patients revealed that they were overall relatively
uncommon (e.g. cardiac arrhythmia 1.5%) [5, 6]. Heart valve disease and arrhythmia are
mainly discussed as causes for the dizziness symptom of presyncope [16]. Another cause for
presyncope seems to be orthostatic hypotension with BP drop on standing [16]. Orthostatic
vertigo defined as vertigo after standing up too fast was excluded in our study to focus on non-
orthostatic subclinical cardiovascular diseases.
Cerebrovascular parameters
Cerebrovascular diseases have a higher potential to cause dizziness compared to cardiac dys-
function, although it is also low with 6% of all dizziness cases in which 2.9% of all cases were
due to stroke and 2.6% due to transient ischemic attack (TIA) [5]. In a population-based set-
ting of patients with dizziness and vertigo symptoms, the symptom of imbalance appeared as a
predictor for stroke and TIA independently of age and sex [17]. Furthermore, dizziness of
abrupt onset and multiple prodromal episodes of dizziness were predictive for stroke in
patients with acute vestibular syndrome (AVS) [18].
Table 3. Association of MRI determined cardiovascular measurements with dizziness and vertigo.
MRI parameter* Dizziness and vertigo







End-diastolic volume/BSA (ml/m2) 1.13 (0.89–1.44) 0.307 0.99 (0.75–1.32) 0.957
End-systolic volume/BSA (ml/m2) 1.14 (0.91–1.44) 0.249 1.12 (0.87–1.45) 0.372
Stroke volume/ BSA (ml/m2) 1.06 (0.84–1.35) 0.615 0.87 (0.65–1.16) 0.341
Ejection Fraction (%) 0.93 (0.74–1.17) 0.560 0.89 (0.69–1.15) 0.371
Myocardial mass, diastolic/BSA (g/m2) 1.18 (0.91–1.53) 0.221 1.10 (0.81–1.51) 0.536
Myocardial mass, systolic/BSA (g/m2) 1.11 (0.84–1.46) 0.482 1.07 (0.77–1.50) 0.688
Right ventricle
End-diastolic volume/BSA (ml/m2) 0.94 (0.72–1.23) 0.666 0.86 (0.62–1.18) 0.343
End-systolic volume/BSA (ml/m2) 0.99 (0.77–1.28) 0.957 0.98 (0.72–1.32) 0.876
Stroke volume/ BSA (ml/m2) 0.94 (0.73–1.22) 0.635 0.80 (0.58–1.10) 0.166
Ejection Fraction (%) 0.99 (0.76–1.29) 0.944 0.89 (0.65–1.22) 0.462
Carotid artery (right and left)
Presence of plaque (AHA lesion type III-VII) (%) 0.50 (0.24–1.02) 0.058 0.44 (0.17–1.12) 0.085
Normalized wall index 1.03 (0.79–1.35) 0.810 1.02 (0.75–1.39) 0.916
Mean wall thickness (mm) 1.07 (0.81–1.4) 0.645 1.07 (0.77–1.47) 0.691
Cerebrum
Presence of WML (%) 1.26 (0.63–2.49) 0.512 1.71 (0.80–3.67) 0.169
Presence of CMB (%) 1.40 (0.72–2.70) 0.319 1.48 (0.70–3.15) 0.304
Data are from logistic regression, adjusted for age, sex, BMI, hypertension and diabetes mellitus.
* SD increment for continuous variables.
BSA, body surface area; WML, white matter lesions; CMB, cerebral microbleeds.
https://doi.org/10.1371/journal.pone.0184858.t003
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PLOS ONE | https://doi.org/10.1371/journal.pone.0184858 September 14, 2017 8 / 13
Similarly to investigating cardiac function, we excluded participants with stroke as an
overt event to characterize subclinical cerebrovascular disease status. A previous study demon-
strated that already small strokes (lesions10 mm) can be present together with isolated AVS
[19].
Fig 1. Prevalence of 12-month dizziness and vertigo according to groups with and without white
matter lesions. In women and men (Panel A) and in persons with normal glucose metabolism and in
prediabetic or diabetic persons (Panel B).
https://doi.org/10.1371/journal.pone.0184858.g001
Fig 2. Prevalence of 12-month dizziness and vertigo according to groups with and without cerebral
microbleeds. In women and men (Panel A) and in persons with normal glucose metabolism and in
prediabetic or diabetic persons (Panel B).
https://doi.org/10.1371/journal.pone.0184858.g002
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Imaging examinations including MRI and computed tomography are often applied to visu-
alize brain abnormalities in dizzy patients [16]. Large WML were observed to be associated
with different balance-related symptoms whereas the influence of small lesions is still unclear
[16]. In our study, the presence of WML was defined as ARWMC ratings 2 (beginning conflu-
ence of lesions) or 3 (diffuse involvement of the entire region) and showed by trend a higher
risk for 12-month prevalence of dizziness and vertigo. This finding supports the tendency of
an association of cerebrovascular disease and dizziness and vertigo. Furthermore, the latter
finding is supported by our result by trend of non-significantly increased dizziness and vertigo
prevalence in participants with CMB.
A contribution of WML as verified by MRI to the occurrence of vertigo was also suggested
by a study of patients with visual vertigo [20]. Another study found a higher frequency of
severe WML in a patients group with unexplained dizziness compared to a group of
explained causes of dizziness [21]. In addition, there is evidence that dizziness might be
more indicative of WML than of silent brain infarcts [22]. The association between CMB
and dizziness and vertigo is less discussed in the literature. However, CMB were reported to
be associated with postural instability measured as the inability to balance on one leg for a
reasonable time [23].
Carotid artery structure
Data for a possible independent association of carotid artery structure including stenosis,
carotid plaque and wall thickness with dizziness and vertigo are rare. Although the impact of
carotid artery stenosis is described as being low and integrated in the general cardiovascular
risk for dizziness [24, 25], some case reports emphasize dizziness as a leading symptom in
patients with carotid artery occlusion [26, 27]. Carotid plaque, normalized wall index and
mean carotid wall thickness seem to be of minor importance for predicting dizziness and ver-
tigo in our study.
Strengths and limitations
For this analysis, MRI was used to assess a broad range of cardiovascular phenotypes allow-
ing well validated continuous measurements. Since this study was nested in the established
KORA cohort project, standardized methods were also available for measuring dizziness and
vertigo as well as the confounding variables BMI and hypertension. The population-based
design is well-suited to investigate subclinical ranges of cardiovascular disease as risk factors
for dizziness and vertigo. Nevertheless, some limitations should be considered. The study
sample of N = 400 is reasonable but might be too small to detect especially small effects of
subclinical cerebrovascular parameter differences on dizziness and vertigo. Power analysis
revealed a detectable dizziness and vertigo proportion difference of 19% points (correspond-
ing OR = 2.6) between control group (N = 354; dizziness and vertigo proportion = 19%) and
the group with WML (N = 46; 38%) with a power of 80%. The MRI sub-study was designed
as a nested case-control study to investigate primarily differences in subclinical cardiovascu-
lar disease between persons with diabetes, prediabetes and controls. Thus, the representative-
ness of the study is not given and results could be biased by selection. However, additional
analyses using weights accounting for differences between MRI sub-study and the whole
cohort did not reveal different results. Furthermore, no effect modification of diabetic status
was found for the association between subclinical cardiovascular diseases and dizziness and
vertigo except borderline significant associations of WML and CMB with dizziness and ver-
tigo in persons with prediabetes or diabetes and in men with normal glucose metabolism,
respectively.
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Conclusion
In this large sample of participants without manifest cardiovascular diseases examined in par-
allel by MRI and symptom assessment of dizziness and vertigo, subclinical left and right ven-
tricular function and carotid structure were consistently not associated with dizziness and
vertigo. Subclinical cerebrum measurements, however, tend to increase the risk for dizziness
and vertigo, especially in men and in persons with prediabetes or diabetes. This slight tendency
of association needs to be validated in larger study samples. The findings support the minor
role of cardiovascular diseases as risk factors for dizziness and vertigo.
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